Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
9.45
+0.04 (0.43%)
At close: Dec 20, 2024, 4:00 PM
9.36
-0.09 (-0.95%)
After-hours: Dec 20, 2024, 6:29 PM EST
Poseida Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -60.76 | -123.43 | -64 | -124.97 | -129.78 | -86.53 | |
| Depreciation & Amortization | 5.48 | 5.61 | 5.17 | 4.55 | 2.59 | 1.19 | |
| Other Amortization | 0.99 | 0.81 | 0.84 | 0.64 | 0.81 | 1.71 | |
| Loss (Gain) From Sale of Assets | 0 | 0 | 0.35 | -0 | - | 0.45 | |
| Loss (Gain) From Sale of Investments | -7.62 | -8.39 | -1.78 | 0.13 | -0.17 | -0.13 | |
| Stock-Based Compensation | 23.03 | 23.13 | 18.93 | 16.7 | 7.22 | 3.05 | |
| Other Operating Activities | - | -3.99 | - | -19.76 | 0.39 | 6.27 | |
| Change in Accounts Receivable | -6.08 | 0.08 | -9.09 | - | - | - | |
| Change in Accounts Payable | 2.67 | 1.04 | -6.75 | 7.84 | -4.17 | 1.53 | |
| Change in Unearned Revenue | 22.08 | 6.73 | 27.3 | 13.76 | - | - | |
| Change in Other Net Operating Assets | 5.18 | 6.23 | 2.26 | -1.44 | 9.79 | 7.94 | |
| Operating Cash Flow | -15.02 | -92.17 | -26.77 | -102.54 | -113.33 | -64.52 | |
| Capital Expenditures | -2.1 | -3.07 | -3.92 | -2.63 | -16.91 | -5.16 | |
| Sale of Property, Plant & Equipment | - | - | 0.01 | 0.02 | - | - | |
| Investment in Securities | 40.26 | 42.2 | -199.42 | 225 | -187.52 | -37.31 | |
| Investing Cash Flow | 38.16 | 39.13 | -203.33 | 222.38 | -204.43 | -42.46 | |
| Long-Term Debt Issued | - | - | 30 | - | - | 10 | |
| Net Debt Issued (Repaid) | - | - | 30 | - | - | 10 | |
| Issuance of Common Stock | 1.29 | 16.62 | 76.61 | 2.52 | 223.98 | 0.07 | |
| Repurchase of Common Stock | -0.59 | -0.49 | - | - | - | - | |
| Other Financing Activities | - | - | -1.45 | - | -19.54 | 4.3 | |
| Financing Cash Flow | 0.7 | 16.13 | 105.16 | 2.52 | 313.94 | 164.37 | |
| Net Cash Flow | 23.84 | -36.91 | -124.95 | 122.36 | -3.82 | 57.39 | |
| Free Cash Flow | -17.13 | -95.23 | -30.7 | -105.18 | -130.24 | -69.67 | |
| Free Cash Flow Margin | -11.35% | -147.18% | -23.52% | -336.70% | - | - | |
| Free Cash Flow Per Share | -0.18 | -1.06 | -0.43 | -1.69 | -3.62 | -5.52 | |
| Cash Interest Paid | 8.09 | 7.8 | 5.14 | 2.72 | 3.03 | 2.63 | |
| Levered Free Cash Flow | -22.24 | -40.72 | -17.93 | -62.14 | -84.2 | -44.49 | |
| Unlevered Free Cash Flow | -17.56 | -36.11 | -14.79 | -60.68 | -82.82 | -43.98 | |
| Change in Net Working Capital | 4.91 | -19.15 | -2.5 | -9.08 | -3.38 | -6.21 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.